metricas
covid
Buscar en
Revista Científica de la Sociedad Española de Enfermería Neurológica (English ed.)
Toda la web
Inicio Revista Científica de la Sociedad Española de Enfermería Neurológica (Englis... Acute disseminated encephalomyelitis (ADEM) following SARS-CoV-2 infection: A ca...
Journal Information
Vol. 59.
Pages 43-47 (January - June 2024)
Share
Share
Download PDF
More article options
Visits
4
Vol. 59.
Pages 43-47 (January - June 2024)
Case report
Acute disseminated encephalomyelitis (ADEM) following SARS-CoV-2 infection: A case report from Iran
Encefalomielitis diseminada aguda (ADEM) tras infección por SARS-CoV-2: caso clínico en Irán
Visits
4
Elnaz Asadollahzadea,
Corresponding author
Drelnazasadollahzade@gmail.com

Corresponding author.
, Sara Azhdarib, Mohammed-Sadegh Joharic, Abdorreza Naser Moghadasid
a Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
b Shiraz University of Medical Sciences, Iran
c Aja University of Medical Sciences, Teheren, Iran
d Tehran University of Medical Sciences, Teheran, Iran
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Abstract

The new coronavirus disease 2019 (COVID-19) outbreak has rapidly spread throughout the world, becoming a serious public health problem. COVID-19, in addition to respiratory symptoms, has neurotropic characteristics that can impact the nervous system. We present a 22-year-old female who developed diplopia and numbness of her limbs eight days after affecting by COVID-19 and she showed a left-sided outward gaze palsy without any history of previous a specific illness or medication. Supratentorial, infratentorial, and cervical cord enhancing plaques confirmed an acute demyelinating process in favor of Acute disseminated encephalomyelitis (ADEM). Her oligoclonal bands (OCB) were positive as well. As a result, a provisional diagnosis of ADEM was made. Her condition improved dramatically after starting corticosteroids and rituximab.

Keywords:
COVID-19
Demyelinating diseases
Post-COVID complications
Acute disseminated encephalomyelitis
SARS-CoV-2
Resumen

El nuevo brote de coronavirus de 2019 (COVID-19) se ha propagado rápidamente a nivel mundial, convirtiéndose en un serio problema de salud pública. La COVID-19, además de síntomas respiratorios, tiene características neurotrópicas que pueden repercutir en el sistema nervioso. Presentamos el caso de una mujer de 22 años que desarrolló diplopía y entumecimiento de las extremidades inferiores 8 días después de verse afectada por la COVID-19, mostrando parálisis de la mirada excéntrica en el lado izquierdo sin antecedentes de enfermedades o medicaciones específicas previas. La intensidad de las placas supratentoriales, infratentoriales y de la columna cervical confirmó un proceso desmielinizante agudo que favorecía encefalomielitis diseminada aguda (ADEM). Asimismo, sus bandas oligoclonales fueron positivas. En consecuencia, se diagnosticó provisionalmente ADEM. Su situación mejoró considerablemente tras iniciar tratamiento con corticosteroides y rituximab.

Palabras clave:
COVID-19
Enfermedades desmielinizantes
Complicaciones post-COVID
Encefalomielitis diseminada aguda
SARS-CoV-2

Article

These are the options to access the full texts of the publication Revista Científica de la Sociedad Española de Enfermería Neurológica (English ed.)
Member
Si es usted socio de SEDENE: Diríjase al área privada de socios de la web de la SEDENE, (https://sedene.com/revista-de-sedene/ ) y autentifíquese.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.sedeng.2022.06.003
No mostrar más